-+ 0.00%
-+ 0.00%
-+ 0.00%

DARÉ BIOSCIENCE ANNOUNCES RETURN OF RIGHTS TO OVAPRENE®; PHASE 3 PROGRAM ONGOING; POSITIVE INTERIM DATA AND GRANT FUNDING POSITION ASSET FOR VALUE-MAXIMIZATION

Reuters·12/01/2025 13:00:05

Please log in to view news